Armis Advisers
ABBV icon

Armis Advisers’s AbbVie ABBV Stock Holding History

Armis Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.61M Buy
16,405
+1,011
+7% +$259K 0.39% 42
2026
Q2 		$3.92M Buy
15,394
+1,289
+9% +$277K 0.36% 47
2026
Q1 		$2.94M Buy
14,105
+86
+0.6% +$19.1K 0.28% 65
2025
Q4 		$2.87M Sell
14,019
-288
-2% -$65.6K 0.32% 55
2025
Q3 		$3.09M Buy
14,307
+1,875
+15% +$382K 0.28% 60
2025
Q2 		$2.37M Buy
12,432
+1,973
+19% +$367K 0.19% 99
2025
Q1 		$2.08M Buy
10,459
+8,007
+327% +$1.56M 0.19% 101
2024
Q4 		$436K Buy
+2,452
New +$451K 0.05% 204

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Armis Advisers's ABBV Position: Q3 2026 in Review

Armis Advisers increased its AbbVie (ABBV) stake by 6.6% in Q3 2026, buying an estimated $259K and bringing the position to 16,405 shares worth $4.61M. The position accounts for 0.39% of the portfolio, ranked #42.

Armis Advisers first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Armis Advisers held 16,405 shares of AbbVie worth $4.61M as of Q3 2026.
  • Armis Advisers bought 1,011 AbbVie shares in Q3 2026, an estimated $259K.
  • AbbVie made up 0.39% of Armis Advisers's portfolio in Q3 2026, its #42 holding.
  • Armis Advisers first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Armis Advisers's 13F filing for Q3 2026, filed 13 Oct 2026.